Publikace

Adamovičová M, Jech R, Urgošík D, Špačková N, Křepelová A. Pallidal stimulation in siblings with pantothenate kinase-associated neurodegeneration - 4 year follow-up. In: Mov Disord 2011/26(1):184-187.

Amirali A, Mu L, Gracies JM, Simpson DM. Anatomical Localization of Motor Endplate Bands in the Human Biceps Brachii. In: J Clin Neuromusc Dis 2007/9(2):306-312.

Anders M, Dvořáková J, Rathová L, Havránková P, Pelcova P, Vaněčková M, Jech R, Holcát M, Seidl Z, Raboch J. Efficacy of repetitive transcranial magnetic stimulation for the treatment of refractory chronic tinnitus: A randomized, placebo controlled study. In: Neuro Endocrinol Lett 2010/31(2):238-249.

Archer J, Gracies JM, Touver E, Crimmins DS, Olgart BS, Milder DG. Bilateral optic disk pallor following unilateral internal carotid occlusion. In: Neurology 1998/50(3):809-811 .

Balcer LJ, Galetta SL, Calabresi PA, Confavreux C, Giovannoni G, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Miller DH, O'Connor PW, Phillips JT, Polman CH, Radue EW, Rudick RA, Stuart WH, Wajgt A, Weinstock-Guttman B, Wynn DR, Lynn F, Panzara MA. Natalizumab reduces visual loss in patients with relapsing multiple sclerosis. In: Neurology 2007/17(16):1299-1304. IF=5,690.

Bareš M, Rektorová I, Jech R, Farníková K, Roth J, Růžička E, Kaňovský P, Rektor I, Pavlík T, Uhlířová L, Vydlák J. Does WOQ-9 help to recognize symptoms of non-motor wearing-off in Parkinson's disease? In: J Neural Transm 2012/119(3):373-380.

Bartoš R, Jech R, Vymazal J, Cihlář F, Hejčl A, Sameš M. Spolehlivost lokalizace primární motorické oblasti pomocí funkční magnetické rezonance. In: Čes Slov Neurol N 2006/102(3):189-194.

Bartoš R, Jech R, Vymazal J, Petrovický P, Hejčl A, Zolal A, Sameš M. Validity of primary motor area localization with fMRI versus electric cortical stimulation. In: Acta Neurochir 2009/151(9):1071-1080.

Bartoš R, Sameš M, Vachata P, Červenka M, Jech R, Vymazal J, Derner M. Výsledky a tolerance "awake" resekcí mozkových nádorů. In: Čes Slov Neurol N 2005/101(1):39-45.

Bartoš R, Sameš M, Vachata P, Jech R, Vymazal J, Petrovický P. Lokalizace funkčních oblastí pomocí elektrické kortikální stimulace (Ojemanova technika) při operacích nádorů mozku. In: Neurologie pro praxi 2007/8(2):118-121.

Bayle N, Gracies JM. Management of deforming spastic paresis. In: Selzer at al. (eds.), Textbook of Neural Repair and Rehabilitation, Cambridge University Press, 2013, v tisku.

Bayle N, Gracies JM. The Syndrome of Deforming Spastic Paresis: Pathophysiology, Assessment and Treatment. In: Cerebral Palsy In Infancy: Optimizing Development Of Functional Motor Performance, Roberta B. Shepherd, Ed, Elsevier Health Sciences, 2013, v tisku.

Bergsland N, Horakova D, Dwyer MG, Dolezal O, Seidl ZK, Vaneckova M, Krasensky J, Havrdova E, Zivadinov R. Subcortical and Cortical Gray Matter Atrophy in a Large Sample of Patients with Clinically Isolated Syndrome and Early Relapsing-Remitting Multiple Sclerosis. In: AJNR Am J Neuroradiol. 2012/12.

Blahova Dusankova J, Kalincik T, Dolezal T, Kobelt G, Havrdova E. Cost of multiple sclerosis in the Czech Republic: The COMS Study. In: Mult Scler. 2011/30.

Bohbot V, Jech R, Bureš J, Nadel L., Růžička E. Spatial and non-spatial memory involvement in myasthenia gravis. In: J Neurol 1997/244(8):529-532.

Bohbot VD, Jech R, Růžička E, Nadel L, Kalina M, Štěpánková K, Bureš J. Rat spatial memory tasks adapted for humans: characterization in subjects with intact brain and subjects with selective medial temporal lobe thermal lesions. In: Physiol Res 2002/51(Suppl 1):S49-64.

Brashear A, Zafonte R, Corcoran M, Galvez-Jimenez N, Gracies JM, Gordon MF, McAfee A, Ruffing K, Thompson B, Williams M, Lee CH, Turkel C.  Inter- and intrarater reliability of the Ashworth Scale and the Disability Assessment Scale in patients with upper-limb poststroke spasticity. In: Arch Phys Med Rehabil. 2002/83(10):1349-1354.

Burke D, Gracies JM, Mazevet D, Meunier S, Pierrot-Deseilligny E. Convergence of descending and various peripheral inputs onto common propriospinal-like neurones in man. In: J Physiol (Lond) 1992/449:655-671.

Burke D, Gracies JM, Mazevet D, Meunier S, Pierrot-Deseilligny E. Non-monosynaptic transmission of the cortical command for voluntary movement in man. In: J Physiol (Lond) 1994/480:191-202.

Burke D, Gracies JM, Meunier S, Pierrot-Deseilligny E. Changes in presynaptic inhibition of afferents to propriospinal-like neurones in man during voluntary contractions. In: J Physiol (Lond) 1992/449: 673-687.

Burt RK, Abinun M, Farge-Bancel D, Fassas A, Hiepe F, Havrdová E, Ikehara S, Loh Y, Marmont du Haut Champ A, Voltarelli JC, Snowden J, Slavin S. Risks of immune system treatments. In: Science. 2010/328(5980):825-826. IF=29.747.

Bušek P, Horáková D, Opavský J, Salinger J, Jech R, Šlachta R, Havrdová E. Krátkodobá spektrální analýza variability srdeční frekvence u roztroušené sklerozy, In: Čes a Slov Neurol a Neuroch 2004/67(1):37-42.

Bušek P, Horáková D, Opavský J, Salinger J, Jech R, Šlachta R, Havrdová E. Krátkodobá spektrální analýza variability srdeční frekvence u roztroušené sklerózy. In: Čes Slov Neurol N 2004/100(1):37-41.

Bušková J, Klempíř J, Majerová V, Picmausová J, Šonka K, Jech R, Roth J, Růžička E. Sleep disturbances in untreated Parkinson's disease. In: J Neurol 2011/258(12):2254-2259.

Calabresi PA, Giovannoni G, Confavreux C, Galetta SL, Havrdova E, Hutchinson M, Kappos L, Miller DH, O'Connor PW, Phillips JT, Polman CH, Radue EW, Rudick RA, Stuart WH, Lublin FD, Wajgt A, Weinstock-Guttman B, Wynn DR, Lynn F, Panzara MA; AFFIRM and SENTINEL Investigators. The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL. In: Neurology 2007/69(14):1391-1403. IF=5,690.

Comi G, Abramsky O, Arbizu T, Boyko A, Gold R, Havrdová E, Komoly S, Selmaj K, Sharrack B, Filippi M; LAQ/5063 Study Group. Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study. In: Mult Scler. 2010/16(11):1360-1366. IF=3.279.

Comi G, Pulizzi A, Rovaris M, Abramsky O, Arbizu T, Boiko A, Gold R, Havrdova E, Komoly S, Selmaj K, Sharrack B, Filippi M; LAQ/5062 Study Group. Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. In: Lancet 2008/371(9630):2085-2092. IF=30.758.

Cubo E, Gracies JM, Benabou R, Olanow CW, Raman R, Leurgans S, Goetz CG. Early Morning Off-Medication Dyskinesias, Dystonia, and Choreic Subtypes. In: Arch Neurol 2001/58(9):1379-1382.

Dolezal O, Dwyer MG, Horakova D, Havrdova E, Minagar A, Balachandran S, Bergsland N, Seidl Z, Vaneckova M, Fritz D, Krasensky J, Zivadinov R. Detection of cortical lesions is dependent on choice of slice thickness in patients with multiple sclerosis. In: Int Rev Neurobiol. 2007/79:475-489. IF=1,724.

Dunne JW, Gracies JM, Hayes M, Zeman B, Singer BJ. A prospective, multicentre, randomized, double-blind, placebo-controlled trial of onabotulinumtoxin A to treat plantarflexor/invertor overactivity after stroke. In: Clin Rehabil 2012/26(9):787-797.

Dušek P, Bušková J, Růžička E, Majerová V, Srp A, Jech R, Roth J, Šonka K. Effects of ropinirole prolonged-release on sleep disturbances and daytime sleepiness in Parkinson disease. In: Clin Neuropharmacol 2010/33(4):186-190.

Dušek P, Jech R, Havránková P, Vymazal J, Wackermann J. Theta-burst transcranial magnetic stimulation overof the supplementary motor area decreases variability of temporal estimates. In: Neuro Endocrinol Lett 2011/32(4):481-486.

Dušek P, Jech R, Sieger T, Vymazal J, Růžička E, Wackermann J, Mueller K. Abnormal activity in the precuneus during time perception in Parkinson's disease: an fMRI Study. In: PLoS ONE 2012/7(1):e29635.

Dušek P, Jech R, Wackermann J, Vymazal J. Effects of dopaminergic therapy on time perception in Parkinson's disease: An event-related fMRI study. In: Proceedings of the 21st Annual Meeting of the International Society for Psychophysics, Fechner Day 2005, 77-82.

Dušek P, Jech R. Vnímání času a jeho poruchy. In: Psychiatrie 2011/15(4):199-207.

El Helou A, Bastuji-Garin S, Paillaud E, Gracies JM, Skalli W, Decq P. Determinants for the Use of Ambulation Aids in a Geriatric Rehabilitation Care Unit: A Retrospective Study. In: J Am Med Dir Assoc. 2012/13(3):279-283.

El Helou A, Gracies JM, Decq P, Skalli W. Estimating foot inertial parameters: A new regression approach. In: Clin Biomech (Bristol, Avon). 2012/27(3):299-305.

Fassas A, Passweg JR, Anagnostopoulos A,Kazis A, Kozak T, Havrdova E, Carreras E, Graus F, Kashyap A, Openshaw H, Schipperus M, Deconinck E, Mancardi G, Marmont A, Hansz J, Rabusin M, Zuazu Nagore FJ, Besalduch J, Dentamaro T, Fouillard L, Hertenstein B, La Nasa G, Musso M, Papineschi F, Rowe JM, Saccardi R, Steck A, Kappos L, Gratwohl A, Tyndall A for the Autoimmune Disease Working Party of the EBMT (European Group for Blood and Marrow Transplantation). Hematopoetic stem cell transplantation for multiple sclerosis: a retrospective study. In: J Neurol. 2002/249(8):1088-1097. IF=3,345.

Frohman EM, Havrdova E, Levinson B, Slanar O. Azathioprine myelosuppression in multiple sclerosis: characterizing thiopurine methyltransferase polymorphisms. In: Mult Scler. 2006/12(1):108-111. IF=2,849.

Frohman EM, Havrdova E, Lublin F, Barkhof F, Achiron A, Sharief MK, Stuve O, Racke MK, Steinman L, Weiner H, Olek M, Zivadinov R, Corboy J, Raine C, Cutter G, Richert J, Filippi M. Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis. In: Arch Neurol. 2006/63(4):614-619. IF=4,835.

Frohman EM, Stuve O, Havrdova E, Corboy J, Achiron A, Zivadinov R, Sorensen PS, Phillips JT, Weinshenker B, Hawker K, Hartung HP, Steinman L, Zamvil S, Cree BA, Hauser S, Weiner H, Racke MK, Filippi M. Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations. In: Arch Neurol. 2005/62(10):1519-1530. IF=4.835.

Gál, O. Reakce na článek K. Řasové a A. Hogenové Kulturní a filozofické rozdíly v Evropě se odrážejí v rehabilitační léčbě (fyzioterapii) neurologicky nemocných, in: Rehabilitace a fyzikální lékařství 2012/4.

Garren H, Robinson WH, Krasulová E, Havrdová E, Nadj C, Selmaj K, Losy J, Nadj I, Radue EW, Kidd BA, Gianettoni J, Tersini K, Utz PJ, Valone F, Steinman L; BHT-3009 Study Group. Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis. In: Ann Neurol. 2008/63(5):611-620. IF=8.717.

Germano IM, Gracies JM, Weisz DJ, Tse W, Koller WC, Olanow CW. Unilateral stimulation of the subthalamic nucleus in Parkinson disease: a double-blind 12-month evaluation study. In: J Neurosurg. 2004/101(1):36-42.

Goodin DS, Biermann LD, Bohlega S, Boiko A, Chofflon M, Gebeily S, Gouider R, Havrdova E, Jakab G, Karabudak R, Karussis D, Miller A, Pakdaman H, Selmaj K, Sharief M; International Working Group for Treatment Optimization in MS. Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosis. In: Curr Med Res Opin. 2007/23(11):2823-2832. IF=3,062.

Gracies  JM, Meunier S, Pierrot-Deseilligny E, Simonetta M. Pattern of propriospinal-like excitation to different species of human upper limb motoneurones. In: J Physiol (Lond) 1991/434:151-167.

Gracies JM, Bayle N, Vinti M, Alkandari S, Vu P, Loche CM, Colas C. Five-step clinical assessment in spastic paresis. In: Eur J Phys Rehabil Med. 2010/46(3):411-421.

Gracies JM, Blondel R, Gault-Colas C, Bayle N. Contrat d’Autorééducation Guidée dans la parésie spastique. De Boeck éditions, ©Association Neurorééducation en Mouvement, 2013.

Gracies JM, Burke K, Clegg NJ, Browne R, Rushing C, Fehlings D, Matthews D, Tilton A, Delgado MR. Reliability of the Tardieu scale for assessing spasticity in children with cerebral palsy. In: Arch Phys Med Rehabil. 2010/91(3):421-428.

Gracies JM, Fitzpatrick R, Wilson L, Burke D, Gandevia SC. Lycra garments designed for patients with upper limb spasticity: mechanical effects in normal subjects. In: Arch Phys Med Rehab 1997/78:1066-1071.

Gracies JM, Lugassy M, Weisz DJ, Vecchio M, Flanagan S, Simpson, DM. Botulinum toxin dilution and endplate targeting in spasticity:  A double-blind controlled study. In: Arch Phys Med Rehab 2009/90:9-16.

Gracies JM, Marosszeky JE, Renton R, Sandanam J, Gandevia SC, Burke D. Short-term effects of dynamic Lycra splints on upper limb in hemiplegic patients. In: Arch Phys Med Rehabil 2000/81:1547-1555.

Gracies JM, Meunier S, Pierrot-Deseilligny E. Evidence for corticospinal excitation of human propriospinal-like neurones. In: J Physiol (Lond) 1994/475:509-518.

Gracies JM, Pierrot-Deseilligny E, Robain G. Evidence for further recruitment of group I fibres with high stimulus intensities when using surface electrodes in man. In: EEG Clin Neurophysiol 1994/93:353-357.

Gracies JM, Simpson DM. Spastic Dystonia. In: Brin MF, C Comella, J Jankovic (eds.), Dystonia: Etiology, Classification, and Treatment. Philadelphia: Lippincott Williams & Wilkins, 2004.

Gracies JM, Tse W, Lugassy M, Frank J. Strategies for Physical Exercise in PD. In: Aminoff, Boller, Schwab (eds.), Parkinson’s disease and related disorders. Handbook of Clin Neurol Series, 3rd ed Vol.84.. Series Ed, W Koller. Elsevier 2007.

Gracies JM. [Neurorehabilitace u parkinsonských syndromů], in: Rev Neurol (Paris). 2010;166(2):196-212 [francouzsky].

Gracies JM. Pathophysiology of Spastic Paresis. Part I. Paresis and Soft Tissue Contracture. In: Muscle Nerve 2005/31(5):535-551.

Gracies JM. Pathophysiology of Spastic Paresis. Part II. The Emergence of Muscle Overactivity. In: Muscle Nerve 2005/31(5):552-571.

Gracies JM. Physiological effects of botulinum toxin in spasticity. In: Mov Dis 2004/19(S8):120-128.

Gracies, JM. et al. Dohoda o reedukačním tréninku při spastické paréze, v přípravě; odborná redakce: M. Hoskovcová, O. Gál.

Gross, JM, Fetto, J., Rosen, E. Vyšetření pohybového aparátu, Triton, Praha 2005; překl: M. Zemanová (=Hoskovcová), J. Vackek.

Hälbig TD, Assuras S, Creighton J, Borod JC, Tse W, Frisina PG, Voustianiouk A, Gracies JM, Olanow CW. Differential role of dopamine in emotional attention and memory: Evidence from Parkinson's disease. In: Mov Disord 2011/26(9):1677-1683.

Hälbig TD, Borod JC, Frisina PG, Tse W, Voustianiouk A, Olanow CW, Gracies JM. Emotional processing affects movement speed. In:  J Neural Transm 2011/118(9):1319-1322.

Hälbig TD, Creighton J, Assuras S, Borod JC, Tse W, Gracies JM, Foldi NS, Kaufmann H, Olanow CW, Voustianiouk A. Preserved emotional modulation of motor response time despite psychomotor slowing in young-old adults. In: Int J Neurosci 2011/121(8):430-436.

Hälbig TD, Kopp UA, Wodarz F, Borod JC, Gracies JM, Ebersbach G, Kupsch A. Dopaminergic modulation of emotional memory in Parkinson's disease. In: J Neural Transm. 2008/115(8):1159-1163.

Hartung HP, Polman C, Bertolotto A, Deisenhammer F, Giovannoni G, Havrdova E, Hemmer B, Hillert J, Kappos L, Kieseier B, Killestein J, Malcus C, Comabella M, Pachner A, Schellekens H, Sellebjerg F, Selmaj K, Sorensen PS. Neutralising antibodies to interferon beta in multiple sclerosis: expert panel report. In: J Neurol. 2007/254(7):827-837. IF=2,984.

Havránková P, Jech R, Roth J, Urgošík D, Růžička E. Beneficial effect of deep brain stimulation of GPi in a Patient with dystonia-deafness phenotype. In: Mov Disord 2009/24(3):465-466.

Havránková P, Jech R, Walker ND, Operto G, Tauchmanová J, Vymazal J, Dušek P, Hromčík M, Růžička E. Repetitive TMS of the somatosensory cortex improves writer's cramp and enhances cortical activity. In: Neuro Endocrinol Lett 2010/31(1):73-86.

Havránková P, Walker ND, Operto G, Sieger T, Vymazal J, Jech R. Cortical pattern of complex but not simple movements is affected in writer's cramp: a parametric event-related fMRI study. In: Clin Neurophysiol 2012/123(4):755-763.

Havrdova E, Galetta S, Hutchinson M, Stefoski D, Bates D, Polman CH, O'Connor PW, Giovannoni G, Phillips JT, Lublin FD, Pace A, Kim R, Hyde R. Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study. In: Lancet Neurol. 2009/8(3):254-260. IF=18,126.

Havrdova E, Galetta S, Stefoski D, Comi G. Freedom from disease activity in multiple sclerosis. In: Neurology. 2010/74(Suppl 3):S3-7. IF=8.172.

Havrdova E, Horakova D, Kovarova I, Krasulova E. Future possibilities of the multiple sclerosis treatment, in: Cas Lek Cesk. 2005/144(10):663-665.

Havrdová E, Horáková D. Roztroušená skleróza. In: Postgraduální medicína 2004/4(6):382-389.

Havrdová E, Týblová M, Štěpán J, Horáková D, Tichá V, Nováková I, Zelená L, Zikán V, Hlásenská J. Výskyt osteoporózy u pacientů s roztroušenou sklerózou v závislosti na míře kortikoterapie a stupni hybného postižení, in: Čes a slov Neurol Neurochir 2004/67(4):234-240.

Havrdova E, Zivadinov R, Krasensky J, Dwyer M, Novakova I, Dolezal O, Ticha V, Dusek L, Houzvickova E, Cox J, Bergsland N, Hussein S, Svobodnik A, Seidl Z, Vaneckova M, Horakova D. Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis. In: Mult Scler. 2009/15(8):965-976.

Havrdova E. Aggressive multiple sclerosis-is there a role for stem cell transplantation?, In:  J Neurol. 2005/252(Suppl 3):iii34-iii37. IF=3.140.

Havrdová E. Fingolimod. In: Remedia 2011/21:297-303.

Havrdová E. Možnosti farmakologické léčby kliniky izolovaného syndromu. In: Farmakoterapie 2009/5(6):629-635.

Havrdová E. Neuroimmunologie, Maxdorf, Praha 2001.

Havrdová E. Roztroušená skleróza mozkomíšní, Triton 1998, 2000, 2002.

Havrdová E. Roztroušená skleróza mozkomíšní: Farmakoterapie, Maxdorf 2006, 2009.

Havrdová E. Roztroušená skleróza, MF Praha 2013.

Havrdová E. Roztroušená skleróza. In: Č a Slov Neurol Neurochir 2008/104(2):121-132. IF=0.319.

Havrdová E. Význam časné léčby roztroušené sklerózy mozkomíšní. In: Neurologie pro praxi 2005/4:291-294.

Hejduková B, Růžička E, Jech R, Jenšovský J. Kognitivní evokované potenciály u subklinické hypothyreosy. In: Čes Slov Neurol N 1999/95(1):13-16.

Holiga S, Möller H E, Sieger T, Schroeter M L, Jech R, Mueller K. Accounting for Movement Increases Sensitivity in Detecting Brain Activity in Parkinson's Disease. In: PLoS ONE 2012/7(5):e36271.

Holiga S, Mueller K, Möller H E, Sieger T, Schroeter M L, Vymazal J, Růžička E, Jech R. Motor matters: Tackling heterogeneity of Parkinson's disease in functional MRI studies. In: PLoS One 2013/8(2):e56133.

Horakova D, Cox JL, Havrdova E, Hussein S, Dolezal O, Cookfair D, Dwyer MG, Seidl Z, Bergsland N, Vaneckova M, Zivadinov R. Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years. A case control study. In: J Neurol Neurosurg Psychiatry. 2007/5. IF=3,63.

Horakova D, Cox JL, Havrdova E, Hussein S, Dolezal O, Cookfair D, Dwyer MG, Seidl Z, Bergsland N, Vaneckova M, Zivadinov R. Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study. In: J Neurol Neurosurg Psychiatry. 2008/79(4):407-414. IF=3,632.

Horáková D, Dwyer M, Havrdová E, Cox JL, Doležal O, Bergsland N, Rimes B, Seidl Z, Vaněčková M, Zivadinov R. Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis. A 5-year longitudinal study. In: J Neurol Sci. 2009/15;282(1-2):112-119.

Horáková D, Havrdová E. Intravenosní imunoglobuliny v léčbě neuroimunitních onemocnění, In: Neurologie, Triton 2005, str. 27-35.

Horakova D, Kalincik T, Dolezal O, Krasensky J, Vaneckova M, Seidl Z, Havrdova E. Early predictors of non-response to interferon in multiple sclerosis. In: Acta Neurol Scand. 2012/16.

Horáková D, Kýr M, Havrdová E, Doležal O, Lelková P, Pospíšilová L, Bergsland N, Dwyer MG, Cox JL, Hussein S, Seidl Z, Vaněčková M, Krásenský J, Zivadinov R. Apolipoprotein E ε4-Positive multiple sclerosis patients develop more gray-matter and whole-brain atrophy: a 15-year disease history model based on a 4-year longitudinal study. In: Folia Biol (Praha) 2010/56(6):242-251. IF=0.924.

Horakova D, Zivadinov R, Weinstock-Guttman B, Havrdova E, Tamaño-Blanco M, Tyblova M, Hussein S, Bergsland N, Willis L, Krasensky J, Vaneckova M, Seidl Z, Lelkova P, Ramanathan M. HLA DRB1*1501 is only modestly associated with lesion burden at the first demyelinating event. In: J Neuroimmunol. 2011/236(1-2):76-80. IF= 2.841.

Hoskovcová M, Ulmanová O, Šprdlík O, Sieger T, Nováková J, Jech R, Růžička E. Disorders of balance and gait in essential tremor are associated with midline tremor and age. In: Cerebellum 2013/12(1):27-34.

Hoskovcová, M. et al. Disorders of balance and gait in essential tremor are associated with midline tremor and age, in: Cerebellum 2013/12(1):27-34.

Hoskovcová, M. et al. Rehabilitace u RS, in:  E. Havrdová et al. (eds.), Je roztroušená skleróza váš problém?, Unie Roska, Praha 2007.

Hoskovcová, M. Léčebná rehabilitace u Parkinsonovy nemoci, in: Parkinson 2010/32:2-4.

Hoskovcová, M. Léčebná rehabilitace v gynekologii a porodnictví (str. 633-635), in: P. Kolář et al. (eds.), Rehabilitace v klinické praxi, Galén, Praha 2009.

Hoskovcová, M. Neurorehabilitace – nejen nové pojmosloví, in: Mladá fronta Zdravotnické noviny ZDN 2011/7:28.

Hoskovcová, M. Parkinsonova nemoc, in: J. Vacek, D. Jandová (eds.), Manuál rehabilitační a fyzikální terapie, Raabe, Praha 2011.

Hoskovcová, M., Gál, O. et al. Rehabilitační postupy u syndromu centrálního motoneuronu, in: A. Štětkářová, R. Jech (eds.), Spasticita, Praha 2012.

Hutchinson M, Kappos L, Calabresi PA, Confavreux C, Giovannoni G, Galetta SL, Havrdova E, Lublin FD, Miller DH, O'Connor PW, Phillips JT, Polman CH, Radue EW, Rudick RA, Stuart WH, Wajgt A, Weinstock-Guttman B, Wynn DR, Lynn F, Panzara MA; AFFIRM and SENTINEL Investigators. The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL. In: J Neurol. 2009/256(3):405-415.

Hutin E, Pradon D, Barbier F, Bussel B, Gracies JM, Roche N. Walking Velocity and Lower Limb Coordination in Hemiparesis. In: Gait Posture 2012/36(2):205-211.

Hutin E, Pradon D, Barbier F, Gracies J-M, Bussel B, Roche N. Lower limb coordination in hemiparetic subjects: impact of botulinum toxin injections into rectus femoris. In: Neurorehabil Neural Repair 2010/24:442-449.

Hutin E, Pradon D, Barbier F, Gracies JM, Bussel B, Roche N. Lower limb coordination in hemiparetic subjects: impact of botulinum toxin injections into rectus femoris. In: Neurorehabil Neural Repair. 2010/24(5):442-449.

Hutin E, Pradon D, Barbier F, Gracies JM, Bussel B, Roche N. Lower limb coordination patterns in hemiparetic gait: factors of knee flexion impairment. In: Clin Biomech (Bristol, Avon) 2011/26(3):304-311.

International Working Group for Treatment Optimization in MS (Havrdová E). Treatment optimization in multiple sclerosis: report of an international consensus meeting. In: Eur J Neurol. 2004/11(1):43-47.

Jakoubková M, Šonka K, Roth J, Růžička E, Jech R, Volfová M, Mečíř P, Nevšímalová S. Poruchy spánku u Parkinsonovy nemoci - subjektivní i objektivní údaje. In: Čes Slov Neurol N 2003/99(6):392-394.

Jakoubková M, Šonka K, Roth J, Růžička E, Michalčíková B, Jech R, Mečíř P, Nevšímalová S. Spánek při Parkinsonově nemoci - dotazníkové šetření. In: Čes Slov Neurol N 2001/97:268-272.

Jech R, Bareš M, Křepelová A, Urgošík D, Havránková P, Růžička E. DYT 6 - a novel THAP1 mutation with excellent effect on pallidal DBS. In: Mov Disord 2011/26(5):924-925.

Jech R, Bareš M, Urgošík D, Černá O, Klement P, Adamovičová M, Příhodová I, Ošlejšková H, Růžička E. Deep brain stimulation in acute management of status dystonicus. In: Mov Disord 2009/11;24(15):2291-2292.

Jech R, Dušek P, Wackermann J, FMRI correlates of time perception. In: A.M. Oliveira, M. Teixeira, G.F. Borges, M.J. Ferro (eds.), Proceedings of the Twentieth Annual Meeting of the International Society for Psychophysics, Fechner Day 2004, 158-163.

Jech R, Dušek P, Wackermann J, Vymazal J. Cumulative BOLD signal changes support the "time accumulator" hypothesis. In: Neuroreport 2005/16(13):1467-1471.

Jech R, Dušek P, Wackermann J, Vymazal J. Vnímání času ve funkčním zobrazení mozku. In: Čas Lék Čes 2005/144(10):678-684.

Jech R, Mueller K, Schroeter ML, Růžička E. Levodopa increases functional connectivity in the cerebellum and brainstem in Parkinson’s disease. In: Brain 2013/doi:10.1093/brain/awt015.

Jech R, Mueller K, Urgošík D, Sieger T, Holiga Š, Růžička F, Dušek P, Havránková P, Vymazal J, Růžička E. The subthalamic microlesion story in Parkinson's disease:  electrode insertion-related motor improvement with relative cortico-subcortical hypoactivation in fMRI. In: PLoS ONE 2012/7(11):e49056.

Jech R, Růžička E, Nebuželský A, Krásenský J, Obenberger J, Seidl Z. Funkční magnetická rezonance a evokované potenciály - základní principy a aplikace. In: Psychiatrie 1999/3(4):228-236.

Jech R, Růžička E, Tintěra J, Urgošík D. Reply: fMRI During Deep Brain Stimulation. In: Mov Disord 2003/18(4):461-462.

Jech R, Růžička E, Urgošík D, Serranová T, Volfová M, Nováková O, Roth J, Dušek P, Mečíř P. Deep brain stimulation of the subthalamic nucleus affects resting EEG and visual evoked potentials in Parkinson's disease. In: Clin Neurophysiol 2006/117(5):1017-1028.

Jech R, Růžička E. Brain stem auditory evoked potentials reflect central nervous system involvement in myasthenia gravis. In: J Neurol 1996/243:547-550.

Jech R, Růžička E. Přípravné evokované potenciály vázané na rychlou složku spontánního nystagmu. In: Klinická Neurofyziologie 1996/13(4):106-109.

Jech R, Šonka K, Růžička E, Nebuželský A, Böhm J, Juklíčková M, Nevšímalová S. Electromagnetic field of mobile phones affects visual event related potential in patients with narcolepsy. In: Bioelectromagnetics 2001/22(7):519-528.

Jech R, Tintěra J, Vymazal J, Urgošík D, Sieger T, Růžička E. Funkční magnetická rezonance u Parkinsonovy nemoci. In: Postgraduální medicína 2003/4(5):454-459.

Jech R, Urgošík D, Tintěra J, Nebuželský A, Krásenský J, Liščák R, Roth J, Růžička E. Functional magnetic resonance imaging during deep brain stimulation: A pilot study in four patients with Parkinson's disease. In: Mov Disord 2001/16(4):1126-1132.

Jech R. Diagnostika svalového hypertonu. In: Štětkářová I, Ehler E, Jech R. (eds.), Spasticita a její léčba, Maxdorf, Praha 2012.

Jech R. Fokální léčba spasticity botulotoxinem. In: Štětkářová I, Ehler E, Jech R. (eds.), Spasticita a její léčba, Maxdorf, Praha 2012.

Jech R. Functional imaging of deep brain stimulation: fMRI, SPECT and PET. In: D. Tarsy, J. Vitek, P. Starr, M. Okun (eds.), DBS in Neurological and Psychiatric Disorders, The Humana Press Inc., Totowa 2008.

Jech R. Hodnocení tíže hybné poruchy u Parkinsonovy nemoci. In: E. Růžička, I. Rektor (eds.), Parkinsonova nemoc: Doporučené postupy diagnostiky a léčby, Galén, GlaxoSmithKline, Praha 2004.

Jech R. Mapování mozku. In: National Geographic Česká republika 2005 - elektronická verze: http://www.nationalgeographic.cz/detail.asp?id=886.

Jech R. Myoklonus a jeho diferenciální diagnostika. In: Postgraduální medicína 2006/8(5):523-528.

Jech R. Onemocnění s abnormálními pohyby. In: Lékařské Listy - příloha Zdravotnických novin 2008/18:22-25.

Jech R. Pohyb s jeho poruchy ve funkčním zobrazení mozku. In: Sanquis 2005/37:32-35.

Jech R. Praktické postupy léčby spastické parézy botulotoxinem. In: Štětkářová I, Ehler E, Jech R. (eds.), Spasticita a její léčba, Maxdorf, Praha 2012.

Jech R. Růžička E, Kognitivní a zrakové funkce ve vzorku starší populace. In: Čas Lék Čes 1995/134(24):791-797.

Jech R. Technické aspekty transkraniální magnetické stimulace. In: M. Bareš, P. Kaňovský, J. Dufek  (eds.), Transkraniální magnetická stimulace, Národní centrum ošetřovatelství a nelékařských zdravotnických oborů, Brno 2003.

Jech R. Transkraniální magnetická stimulace u cévních mozkových příhod. In: M. Bareš, P. Kaňovský, J. Dufek  (eds.), Transkraniální magnetická stimulace, Národní centrum ošetřovatelství a nelékařských zdravotnických oborů, Brno 2003.

Jech R. Úvod do Spasticity. In: Štětkářová I, Ehler E, Jech R. (eds.), Spasticita a její léčba, Maxdorf, Praha 2012.

Jech R., Klempíř J., Vymazal J., Židovská J., Klempířová O., Růžička E., Roth J. Variation of selective gray and white matter atrophy in Huntington's disease. In: Mov Disord 2007/ 22(12):1783-1789.

Jiroutek P, Růžička E, Roth J, Jech R. Slowly progressive voluntary-automatic dissociation of facial movements (Foix-Chavany-Marie syndrome). In: Neuro Endocrinol Lett 2007/28(2):137-140.

Kalincik T, Horakova D, Dolezal O, Krasensky J, Vaneckova M, Seidl Z, Havrdova E. Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort. In: Clin Neurol Neurosurg. 2012/6.

Kalistová H, Havrdová E, Uhrová J, Zeman D, Týblová M, Mrázová K. Myelin basic protein in multiple sclerosis and other neurological disorders. In: J Neurol 2003/250:874-875.

Kalousova M, Havrdova E, Mrazova K, Spacek P, Braun M, Uhrova J, Germanova A, Zima T. Advanced glycoxidation end products in patients with multiple sclerosis. In: Prague Med Rep. 2005/106(2):167-174.

Kappos L, Bates D, Edan G, Eraksoy M, Garcia-Merino A, Grigoriadis N, Hartung HP, Havrdová E, Hillert J, Hohlfeld R, Kremenchutzky M, Lyon-Caen O, Miller A, Pozzilli C, Ravnborg M, Saida T, Sindic C, Vass K, Clifford DB, Hauser S, Major EO, O'Connor PW, Weiner HL, Clanet M, Gold R, Hirsch HH, Radü EW, Sørensen PS, King J. Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring. In: Lancet Neurol. 2011/10(8):745-758.

Kappos L, Bates D, Hartung HP, Havrdova E, Miller D, Polman CH, Ravnborg M, Hauser SL, Rudick RA, Weiner HL, O'Connor PW, King J, Radue EW, Yousry T, Major EO, Clifford DB. Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring. In: Lancet Neurol. 2007/6(5):431-441. IF=9,479.

Kappos L, Gold R, Miller DH, MacManus DG, Havrdova E, limmroth V et al. Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. In: Lancet 2008/372:1463-72. IF= 30.758.

Kappos L, Gold R, Miller DH, Macmanus DG, Havrdova E, Limmroth V, Polman CH, Schmierer K, Yousry TA, Eraksoy M, Meluzinova E, Dufek M, Yang M, Dawson K, O'Neill GN. Effect of BG-12 on contrast-enhancing lesions in patients with relapsing-remitting multiple sclerosis: subgroup analyses from the phase 2b study. In: Mult Scler. 2011/30.

Karussis D, Biermann LD, Bohlega S, Boiko A, Chofflon M, Fazekas F, Freedman M, Gebeily S, Gouider R, Havrdova E, Jakab G, Karabudak R, Miller A. the International Working Group for Treatment Optimization in MS.A recommended treatment algorithm in relapsing multiple sclerosis: report of an international consensus meeting. In: Eur J Neurol. 2006/13(1):61-71. IF=2,225.

Kaufmann H, Bhattacharya KF, Voustianiouk A, Gracies JM. Stimulation of the subthalamic nucleus increases heart rate in patients with Parkinson’s disease. In: Neurology 2002/59:1657-1658.

Keclíková (=Suchá), L. Cvičení při roztroušené skleróze 1, DVD a brožura pro pacienty s RS, Klub mladých sklerotiků 2008.

Keclíková (=Suchá), L. Cvičení při roztroušené skleróze 2, DVD a brožura pro pacienty s RS, Klub mladých sklerotiků 2009.

Keclíková (=Suchá), L., Hoskovcová, L., Havrdová, E. Role fyzioterapie v managementu RS, in: Neurologie pro praxi 2012/13 (Suppl. C).

Keclíková (=Suchá), L., Hoskovcová, M., Honsová, K. Rehabilitace u roztroušené sklerózy, in: Neurologie pro praxi 2008/9(4):232-235.

Keller J, Vymazal J, Ridzoň P, Rusina R, Kulišťák P, Malíková H, Rulseh AM, Keller O, Jech R. Quantitative Brain MR Imaging in Amyotrophic Lateral Sclerosis. In: MAGMA 2011/24(2):67-76.

Kiernan MC, Hales JP, Gracies JM, Mogyoros I, Burke D. Paraesthesiae induced by prolonged high frequency stimulation of human cutaneous afferents. In: J Physiol (Lond) 1997/501:461-471.

Kiernan MC, Mogyoros I, Hales JP, Gracies JM, Burke D. Excitability changes in human cutaneous afferents induced by prolonged repetitive axonal activity. In: J Physiol (Lond), 1997/500:255-264.

Klempířová O, Jech R, Urgošík D, Klempíř J, Špačková N, Roth J, Růžička E. Deep Brain Stimulation of the Subthalamic Nucleus and Cognitive Functions in Parkinson´s disease. In: Prague Medical Report 2007/108(4):315-323.

Kozák T,  Havrdová E , Piťha J ,  Gregora E  et al. High dose  immunosuppression with hemopoietic stem cell support in the treatment of multiple sclerosis. In: IMAJ 2000/8:610-614.

Kozák T,  Havrdová E , Piťha J,  Gregora E  et al. High dose  immunosuppressive  therapy  with  PBPC  support  in the  treatment  of  poor  risk  multiple  sclerosis. In: Bone Marrow Transplant 2000/25(5):525-531.

Kozák T, Havrdová E, Piťha J, Gregora E, Pytlík R, Maaloufová J, Kobylka P, Vodvářková Š. Immunoablative Therapy with Autologous Stem Cell Transplantation in the Treatment of Poor Risk Multiple Sclerosis. In: Transplantation Proceedings 2001/33(3):2179-2181.

Krasulová E, Havrdová E. Léčba relaps-remitentní roztroušené sklerózy. In: Neurol.pro praxi 2008/9(4):218-222.

Krasulová E, Havrdová E. Současná léčba relaps-remitentní roztroušené sklerózy a perspektivy do budoucna. In: Klinická farmakologie a farmacie 2008/1(22):23-29.

Krasulová E, Trneny M, Kozák T, Vacková B, Pohlreich D, Kemlink D, Kobylka P, Kovárová I, Lhotáková P, Havrdová E. High-dose immunoablation with autologous haematopoietic stem cell transplantation in aggressive multiple sclerosis: a single centre 10-year experience. In: Mult Scler. 2010/16(6):685-693. IF=3.279.

Línek V, Roth J, Jech R, Volfová M, Růžička E. Vliv dopaminerní stimulace u Parkinsonovy nemoci na deklarativní a nedeklarativní paměť. In: Čes Slov Neurol N 2001/97:109-113.

Macaš M, Lhotská L, Bakstein E, Novák D, Wild J, Sieger T, Vostatek P, Jech R. Wrapper feature selection for small sample size data driven by complete error estimates. In: Comput Methods Programs Biomed 2012/108(1):138-150.

MacManus DG, Miller DH, Kappos L, Gold R, Havrdova E, Limmroth V, Polman CH, Schmierer K, Yousry TA, Eraksoy M, Meluzinova E, Dufek M, Yang M, O'Neill GN, Dawson K. BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosis. In: J Neurol. 2011/258(3):449-56. IF=2.903.

Mareckova H, Havrdova E, Krasulova E, Vankova Z, Koberová M, Sterzl I. Natalizumab in the treatment of patients with multiple sclerosis: first experience. In: Ann N Y Acad Sci. 2007/1110:465-473. IF=1,930.

Marchetti A, Magar R, Findley L, Larsen JP, Pirtosek Z, Růžička E, Jech R, Slawek J, Ahmed F. Retrospective evaluation of the dose of dysport and BOTOX in the management of cervical dystonia and blepharospasm: The REAL DOSE study. In: Mov Disord 2005/20(8):937-944.

Masek M, Vaneckova M, Krasensky J, Danes J, Havrdova E, Hrebikova T, Seidl Z. Secondary-progressive form of multiple sclerosis: MRI changes versus clinical status. In: Neuro Endocrinol Lett. 2008/29(4):461-466. IF=1,047.

Meyniel C, Spelman T, Jokubaitis VG, Trojano M, Izquierdo G, Grand'maison F, Oreja-Guevara C, Boz C, Lugaresi A, Girard M, Grammond P, Iuliano G, Fiol M, Cabrera-Gomez JA, Fernandez-Bolanos R, Giuliani G, Lechner-Scott J, Cristiano E, Herbert J, Petkovska-Boskova T, Bergamaschi R, van Pesch V, Moore F, Vella N, Slee M, Santiago V, Barnett M, Havrdova E, Young C, Sirbu CA, Tanner M, Rutherford M, Butzkueven H; on behalf of the MSBasis Study Group. Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. In: PLoS One. 2012/7(6):e38661.

Miller DH, Soon D, Fernando KT, MacManus DG, Barker GJ, Yousry TA, Fisher E, O'Connor PW, Phillips JT, Polman CH, Kappos L, Hutchinson M, Havrdova E, Lublin FD, Giovannoni G, Wajgt A, Rudick R, Lynn F, Panzara MA, Sandrock AW; AFFIRM Investigators. MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS. In: Neurology 2007/24(17):1390-1401. IF=5,690.

Mogyoros I, Kiernan M, Gracies JM, Burke D. The effects of stimulus duration on the latency of submaximal nerve volleys. In: Muscle Nerve 1996/19:1354-1356.

Moore ST, MacDougall HG, Gracies J-M, Cohen HS, Ondo WG. Long-term monitoring of gait in Parkinson disease. In: Gait Posture 2007/26(2):200-207.

Moore ST, Macdougall HG, Gracies JM, Ondo WG. Locomotor response to levodopa in fluctuating Parkinson's disease. In: Exp Br Res 2008/184(4):469-478.

Mueller K, Jech R, Schroeter M L. Deep-brain stimulation for Parkinson´s disease. In: N Eng J MED 2013/368(5):482-483.

Novák D, Wild J, Sieger T, Jech R. Identifying number of neurons in extracellular recording. In: 4th International IEEE/EMBS Conference on Neural Engineering, NER 2009;5109403:742-745.

Nováková J, Hromčík M, Jech R. Dynamic Casual Modeling and subspace identification methods. In: Biomedical Signal Processing and Control 2012/7:365-370.

Nováková L, Haluzík M, Jech R, Urgošík D, Růžička F, Růžička E. Hormonal regulators of energy homeostasis and weight gain in Parkinson's disease after subthalamic nucleus stimulation. In: Neuro Endocrinol Lett 2011/32(4):437-441.

Nováková L, Růžička E, Jech R, Serranová T, Dušek P, Urgošík D. Increase in body weight is an non-motor side effect of deep brain stimulatin of the subthalamic nucleus in Parkinson's disease. In: Neuro Endocrinol Lett 2007/28(1):21-25.

Obenberger J, Seidl Z, Krásenský J, Růžička E, Jech R. Funkční magnetická rezonance - spojení anatomie mozku s jeho funkcí, zobrazení funkčních stavů mozku na pozadí anatomického detailu. In: Čes Radiol 1998/52(2):88-94.

Olanow CW, Gracies JM, Goetz CG, Stoessl AJ, Freeman T, Kordower JH, Godbold J, Obeso JA. Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: A double blind video-based analysis. In: Mov Disord. 2009/24(3):336-343.

Paus T, Jech R, Thompson CJ, Comeau R, Peters T, Evans AC. Transcranial Magnetic Stimulation during Positron Emisssion Tomography: A New Method for Studying Connectivity of the Human Cerebral Cortex. In: J Neurosci 1997/17(9):3178-3184.

Paus T, Jech R, Thompson CJ, Comeau R, Peters T. Evans A C, Dose-Dependent Reduction of Cerebral Blood Flow During Rapid-Rate Transcranial Magnetic Stimulation of the Human Sensorimotor Cortex. In: J Neurophysiol 1998/79(2):1102-1107.

Páv M, Kovářů H, Fišerová A, Havrdová E, Lisá V. Neurobiological aspects of depressive disorder and antidepressant treatment: role of glia. In: Physiol Res. 2008/57(2):151-164. IF=2,093.

Pezard L, Jech R, Růžička E. Investigation of non-linear properties of multichannel EEG in the early stages of Parkinson´s disease. In: Clin Neurophysiol 2001/112:38-45.

Pezard L, Jech R, Růžička E., Investigation of non-linear properties of multichannel EEG in the early stages of Parkinson´s disease. In: Clin Neurophysiol 2001/112(1):38-45.

Phillips JT, O'Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, Polman CH, Lublin FD, Giovannoni G, Wajgt A, Lynn F, Panzara MA, Sandrock AW; AFFIRM Investigators. Infusion-related hypersensitivity reactions during natalizumab treatment. In: Neurology 2006/14;67(9):1717-1718. Erratum in: Neurology 2007/6;68(6):473. IF=5,690.

Piťha J, Havrdová E. Axonální patologie u roztroušené sklerózy. In: Čes a Slov Neurol a Neuroch 2005/68(3):154-158.

Polman CH, O´Connor P, Havrdová E et al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. In: NEJM,2006/354(9):899-910. IF=38,570.

Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. In: Ann Neurol. 2011/69(2):292-302. IF= 9.317.

Rasova K, Brandejsky P, Havrdova E, Zalisova M, Rexova P. Spiroergometric and spirometric parameters in patients with multiple sclerosis: are there any links between these parameters and fatigue, depression, neurological impairment, disability, handicap and quality of life in multiple sclerosis?, In: Mult Scler. 2005/11(2):213-221. IF=2.849.

Rasova K, Havrdova E, Brandejsky P, Zalisova M, Foubikova B, Martinkova P. Comparison of the influence of different rehabilitation programmes on clinical, spirometric and spiroergometric parameters in patients with multiple sclerosis. In: Mult Scler. 2006/12(2):227-234. IF=2,849.

Rasova K, Krasensky J, Havrdova E, Obenberger J, Seidel Z, Dolezal O, Rexova P, Zalisova M. Is it possible to actively and purposely make use of plasticity and adaptability in the neurorehabilitation treatment of multiple sclerosis patients? A pilot project. In: Clin Rehabil. 2005/19(2):170-181. IF=1.115.

Roth J, Havrdova E, Ruzicka E. Atrophy of caudate nucleus in Huntington´s disease measured by computed tomography. In: J Neurol 2000/415:880-881.

Roth J, Klempíř J, Jech R, Židovská J, Uhrová T, Doubek P, Ulmanová O, Brožová H, Volfová M, Serranová T, Růžička E. Caudate nucleus atrophy in Huntington's disease and its relationship with clinical and genetic parameters. In: Funct Neurol 2005/20(3):127-130.

Roth J, Růžička E, Svobodová I, Jech R, Mečíř P. Dopaminergic responsiveness of hypokinesia but not of rigidity and tremor is reduced in fluctuating Parkinson's disease. In: A. Fisher (ed.), Advances in Behavioral Sciences, volume 49: Progress in Alzheimer's and Parkinson's Diseases, Plenum Press, New York 1998; 435-438.

Roth J, T. Radil, Růžička E, Jech R, Tichý J. Apomorphine does not influence olfactory thresholds in Parkinson's disease. In: Funct Neurol 1998/2(13):99-103.

Roth J, Židovská J, Růžičková Š, Havrdová E, Uhrová T, Preiss N, Línek V, Wolfová M, Růžička E, Jech R, Bauer J. The relationship between clinical signs, the atrophy of caudate nucleus and CAG triplets repeat in Huntington´s Disease.  In: J Neurol 1998/245:454.

Roth J, Židovská J., Růžičková Š, Havrdová E, Preiss M, Uhrová T, Línek V, Doubek P, Volfová M, Jech R, Bauer J, Růžička E. Huntigton's disease: The relationship between clinical signs, CAG repeats and the atrophy of the caudate nucleus in CT scans. In: Sb lék 1999/1(100):39-44.

Rothová Z, Jech R. Reziduální nálezy u retrobulbárních neuritid při demyelinizaci. In: Čes Slov Oftalomol 1998/54(2):95-99.

Rudick RA, Miller D, Hass S, Hutchinson M, Calabresi PA, Confavreux C, Galetta SL, Giovannoni G, Havrdova E, Kappos L, Lublin FD, Miller DH, O'Connor PW, Phillips JT, Polman CH, Radue EW, Stuart WH, Wajgt A, Weinstock-Guttman B, Wynn DR, Lynn F, Panzara MA; AFFIRM and SENTINEL Investigators. Health-related quality of life in multiple sclerosis: effects of natalizumab. In: Ann Neurol. 2007/62(4):335-346. IF=8,051.

Růžička E, Jech R, Roth J, Michalčíková B, Mečíř P, Volfová M. Agonisté dopaminu v léčbě Parkinsonovy nemoci: Zkušenost s pergolidem. In: Čes Slov Neurol N 2000/5:283-290.

Růžička E, Jech R, Zárubová K, Roth J, Urgošík D. VIM thalamic stimulation for tremor in a patient with IgM paraproteinaemic demyelinating neuropathy. In: Mov Disord 2003/18(10):1192-1195.

Růžička E, Nováková L, Jech R, Urgošík D, Růžička F, Haluzík M. Decrease in Blood Cortisol Corresponds to Weight Gain following Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease. In: Stereotact Funct Neurosurg 2012/90:410-411.

Růžička E, Roth J, Jech R, Bušek P. Subhypnotic doses of zolpidem oppose dopaminergic-induced dyskinesia in Parkinson´s disease. In: Mov Disord 2000/15:734-735.

Růžička E, Roth J, Jech R, Bušek P. Subhypnotic doses of zolpidem oppose dopaminergic-induced dyskinesia in Parkinson´s disease. In: Mov Disord 2000/15:734-735.

Růžička E, Roth J, Špačková N, Mečíř P, Jech R. Apomorfin a kognitivní funkce u Parkinsonovy nemoci. In: Čes Slov Neurol N 1994/90(6):258-264.

Růžička E, Roth J, Špačková N, Mečíř P, Jech R. Apomorphine-induced cognitive changes in Parkinson's disease. In: J Neurol Neurosurg Psychiatry 1994/57:998-1001.

Růžička E, Streitová H, Jech R, Kaňovský P, Roth J, Rektorová I, Mečíř P, Hortová H, Bareš M, Hejduková B, Rektor I. Amantadine infusion in treatment of motor fluctuations and dyskinesias in Parkinson´s disease. In: J Neural Transm 2000/107:1297-1306.

Růžička E, Streitová H, Jech R, Kaňovský P, Roth J, Rektorová I, Mečíř P, Hortová H, Bareš M, Hejduková B, Rektor I. Amantadine infusion in treatment of motor fluctuations and dyskinesias in Parkinson´s disease. In: J Neural Transm 2000/107:1297-1306.

Růžička E, Urgošík D, Jech R, Roth J, Vymazal J, Mecir P, Vladyka V. Hemiparkinsonism and levodopa-induced dyskinesias after focal nigral lesion. In: Mov Disord 2005/20(6):759-762.

Růžička E, Urgošík D, Jech R, Roth J, Vymazal J, Mečíř P, Vladyka V. Reply - Hemiparkinsonism and levodopa-induced dyskinesias after focal nigral lesion. In: Mov Disord 2006/21(12):2268.

Růžička E, Urgošík D, Jech R, Serranová T, Volfová M, Roth J, Vymazal J, Mečíř P, Nováková L, Nováková O, Ulmanová O, Brožová H, Dušek P, Špačková N, Liščák R, Vladyka V. Hluboká mozková stimulace v léčbě Parkinsonovy nemoci a třesu: Pražská zkušenost 1998-2003. In: Čes Slov Neurol N 2004/100(6):423-436.

Růžička E, Urgošík D, Jech R. Hluboká mozková stimulace v léčbě extrapyramidových poruch. In: Lékařské listy 2003/2:28-31.

Růžička F, Jech R, Nováková L, Urgošík D, Vymazal J, Růžička E. Weight gain is associated with medial contact site of subthalamic stimulation in Parkinson's disease. In: PLoS ONE 2012/7(5):e38020.

Řasová K, Brandejský P, Tintěra J, Krásenský J, Zimová J, Medová E, Herbenová A, Kalistová H, Jech R, Řasová M, Zemanová P, Zeman J, Ibrahim I, Martinková P, Doležil P, Jandová D. Bimanuální sekvenční motorická úloha u roztroušené sklerózy mozkomíšní v obraze funkční magnetické rezonance: Vliv fyzioterapeutických technik - Pilotní studie. In: Čes Slov Neurol N 2009/72(4):350-358.

Saccardi R, Kozak T, Bocelli-Tyndall C, Fassas A, Kazis A, Havrdova E, Carreras E, Saiz A, Lowenberg B, te Boekhorst PA, Gualandio F, Openshaw H, Longo G, Pagliai F, Massacesi L, Deconink E, Ouyang J, Nagore FJ, Besalduch J, Lisukov IA, Bonini A, Merelli E, Slavino S, Gratwohl A, Passweg J, Tyndall A, Steck AJ, Andolina M, Capobianco M, Martin JL, Lugaresi A, Meucci G, Saez RA, Clark RE, Fernandez MN, Fouillard L, Herstenstein B, Koza V, Cocco E, Baurmann H, Mancardi GL; Autoimmune Diseases Working Party of EBMT. Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. In: Mult Scler. 2006/12(6):814-823. IF=2,849.

Sánchez D, Tučková L, Šebo P, Michalak M, Whelan A, Šterzl I, Jelínková L, Havrdová E, Imramovská M, Beneš Z, Krupičková S, Tlaskalová-Hogenová H. Occurence of IgA and IgG autoantibodies to calreticulin in coelic disease and various autoimmune diseases. In: J Autoimmunity 2000/15:441-449.

Serranová T, Jech R, Dušek P, Sieger T, Růžička F, Urgošík D, Růžička E. Subthalamic nucleus stimulation affects incentive salience attribution in Parkinson's disease. In: Mov Disord 2011/26(12):2260-2266.

Serranová T, Jech R, Marti M J, Modreanu R, Valldeoriola F, Sieger T, Růžička E, Valls-Solé J. A loud auditory stimulus overcomes voluntary movement limitation in cervical dystonia. In: PLoS ONE 2012/7(10):e46586.

Serranová T, Sieger T, Dušek P, Růžička F, Urgošík D, Růžička E, Valls-Solé J, Jech R. Sex, food and threat: Startling changes after subthalamic stimulation in Parkinson’s disease. In: Brain Stim 2013/6(5):740-745.

Serranová T, Valls-Solé J, Munoz E, Genís D, Jech R, Seeman P. Abnormal corticospinal tract modulation of the soleus H reflex in patients with pure spastic paraparesis. In: Neurosci Lett 2008/437(1):15-19.

Sieger T, Bonnet C, Serranová T, Wild T, Novák D, Růžička F, Urgošík D, Růžička E, Gaymard B, Jech R. Basal ganglia neuronal activity during scanning eye movements in Parkinson’s disease. In: PLoS ONE (v tisku).

Simpson DM, Gracies JM, Graham HK, Miyasaki JM, Naumann M, Russman B, Simpson LL, So Y. Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. In: Neurology 2008/70(19):1691-1698.

Simpson DM, Gracies JM, Yablon SA, Barbano R, Brashear A. BoNT/TZD Study Team. Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study. In: J Neurol Neurosurg Psychiatry 2009/80(4):380-385.

Sørensen PS, Bertolotto A, Edan G, Giovannoni G, Gold R, Havrdova E, Kappos L, Kieseier BC, Montalban X, Olsson T. Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab. In: Mult Scler. 2012/18(2):143-152.

Stepan JJ, Havrdova E, Tyblova M, Horakova D, Ticha V, Novakova I, Zikan V. Markers of bone remodeling predict rate of bone loss in multiple sclerosis patients treated with low dose glucocorticoids. In: Clin Chim Acta. 2004/348(1-2):147-154. IF=1.633.

Sterio D, Rezai A, Mogilner A, Zonenshayn M, Gracies JM, Kathirithamby K, Beric A. Neurophysiological modulation of the subthalamic nucleus by pallidal stimulation in Parkinson's disease. In: J Neurol Neurosurg Psychiatry 2002/72(3):325-328.

Šprdlík O.,Hurák Z., Hoskovcová M. et al. Tremor Analysis by Decomposition of Acceleration into Gravity and Inertial Acceleration Using Inertial Measurement Unit. In: Biomed Signal Process Control 2011/6:269-279.

Štětkářová, I., Ehler, E., Jech, R. (eds.). Spasticita a její léčba, Maxdorf 2012, Praha 2012.

Suchá L, Hoskovcová M, Gál O. Úloha fyzioterapie v léčbě RS, in: E. Havrdová (ed.), Roztroušená skleróza, MF Praha 2013, str. 397-409.

Timmermann L, Pauls K A M, Wieland K, Jech R, Kurlemann G, Sharma N, Gill S S, Haenggeli C A, Hayflick S J, Hogarth P, Leenders K L, Limousin P, Malanga C J, Moro E, Ostrem J L, Revilla F J, Santens P, Schnitzler A, Tisch S, Valldeoriola F, Vesper J, Volkmann J, Woitalla D, Peker S. Dystonia in Neurodegeneration with Brain Iron Accumulation: outcome of bilateral pallidal stimulation. In: Brain 2010/133(3):701-712.

Tse W, Cersosimo MG, Gracies JM, Morgello S, Olanow CW, Koller W.  Movement disorders and AIDS: a review. In: Parkinsonism Relat Disord 2004/10(6):323-334.

Tse W, Frisina PG, Hälbig TD, Gracies JM, Liang L, Tarshish C, Lesser G, Neufeld R, Koller WC, Libow LS. The effects of withdrawal of dopaminergic medication in nursing home patients with advanced parkinsonism. In: J Am Med Dir Assoc 2008/9(9):670-675.

Tse W, Libow LS, Neufeld R, Lesser G, Frank J, Dolan S, Tarshish C, Gracies JM, Olanow CW, Koller WC, Halbig TD. Prevalence of movement disorders in an elderly nursing home population. In: Arch Gerontol Geriatr 2008/46(3):359-366.

Tse W, Liu Y, Barthlen GM, Hälbig TD, Tolgyesi SV, Gracies JM, Olanow CW, Koller WC. Clinical Usefulness Of The Parkinson’s Disease Sleep Scale. In: Parkinsonism Relat Disord. 2005/11(5):317-321.

Uhríková Z., Šprdlík O., Hoskovcová M. et al. Validation of a new tool for automatic assessment of tremor frequency from video recordings. In: Journal of Neuroscience Methods 2011/198:110-113.  

Ulmanová O, Homann C. N, Ulman R, Jech R, Čapek V, Klempíř J, Růžička E. Tremor magnitude: a single index to assess writing and drawing in essential tremor. In: Parkinsonism Relat Disord 2007/13(4):250-253.

Urgošík D, Jech R, Růžička E, Růžička F, Liščák R, Vladyka V. Hluboká mozková stimulace u extrapyramidových poruch pohybu - pražská zkušenost. In: Čas Lék Čes 2011/150(4-5):223-228.

Urgošík D, Jech R, Růžička E. Hluboká mozková stimulace u nemocných s extrapyramidovými poruchami pohybu - stereotaktická procedura a intraoperační nálezy. In: Čes Slov Neurol N 2011/107(2):175-186.

Urgošík D, Jech R, Růžička E. Stereotaktická funkční neurochirurgie u extrapyramidových pohybových poruch. In: Sanquis 2005/37:21-23.

Urgošík D, Růžička E, Jech R. Funkční neurochirurgická léčba extrapyramidových poruch. In: Postgraduální medicína 2003/4(5):448-453.

Vaneckova M, Kalincik T, Krasensky J, Horakova D, Havrdova E, Hrebikova T, Seidl Z. Corpus Callosum Atrophy - A Simple Predictor of Multiple Sclerosis Progression: A Longitudinal 9-Year Study. In: Eur Neurol. 2012/68(1):23-27.

Vaneckova M, Seidl Z, Krasensky J, Havrdova E, Horakova D, Dolezal O, Burgetova A, Masek M. Patients' stratification and correlation of brain magnetic resonance imaging parameters with disability progression in multiple sclerosis. In: Eur Neurol. 2009/61(5):278-284. IF=1.494.

Vaňková J, Štěpánová I, Jech R, Elleder M, Ling L, Mignot E, Nishino S, Nevšímalová S. Sleep disturbances and hypocretin deficiency in Niemann-Pick disease type C. In: Sleep 2003/26(4):427-430.

Vassel P, Karoubi E, Robain G, Perrigot M, Roman F, Coulomb T, Combes T, Gracies JM, Jacquet M. Evaluation prospective de la rééducation périnéale chez 150 personnes âgées incontinentes, vivant en institution. In: Ann Réadapt Méd Phys (Paris) 1989/31.

Vávrová J, Kemlink D, Sonka K, Havrdová E, Horáková D, Pardini B, Müller-Myhsok B, Winkelmann J. Restless legs syndrome in Czech patients with multiple sclerosis: An epidemiological and genetic study. In: Sleep Med. 2012/13(7):848-851.

Veselá O, Růžička E, Jech R, Roth J, Mečíř P, Volfová M. Esenciální tremor v naší populaci nemocných - základní charakteristika onemocnění a vyšetření kresbou spirály. In: Čes Slov Neurol N 2002/65(3):180-186.

Veselá O, Růžička E, Jech R, Roth J, Štěpánková K, Mečíř P, Solano Z, Preclíková E. Colour discrimination impairment is not a reliable early marker of Parkinson's disease. In: J Neurol 2001/248:975-978.

Vinti M, Costantino, Bayle N, Simpson DM, Weisz DJ, Gracies JM. Spastic cocontraction in Hemiparesis. Effects of Botulinum Toxin. In: Muscle and Nerve 2012/46(6):917-925.

Vinti M, Couillandre A, Hausselle J, Bayle N, Primerano A, Merlo A, Hutin E, Gracies JM. Influence of Effort Intensity and Gastrocnemius Stretch on Co-contraction and Torque Production in the Healthy and Paretic Ankle. In: Clin Neurophysiol 2013/124(3):528-535.

Vymazal J, Klempíř J, Jech R, Židovská J, Syka M, Růžička E, Roth J. MR Relaxometry in Huntington's Disease: Correlation between Imaging, Genetic and Clinical Parameters. In: J Neurol Sci 2007/263(1-2):20-25.

Weinstock-Guttman B, Galetta SL, Giovannoni G, Havrdova E, Hutchinson M, Kappos L, O'Connor PW, Phillips JT, Polman C, Stuart WH, Lynn F, Hotermans C. Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS. In: J Neurol. 2011/19.

Wild J, Prekopcsak Z, Sieger T, Novak D, Jech R. Performance comparison of extracellular spike sorting algorithms for single-channel recordings. In: J Neurosci Methods 2012/203(2):369-376.

Wilson LR, Gandevia SC, Inglis JT, Gracies JM, Burke D. Muscle spindle activity in the affected upper limb after a unilateral stroke. In: Brain 1999/122: 2079-2088.

Wilson LR, Gracies JM, Burke D, Gandevia SC. Evidence for fusimotor drive in stroke patients based on muscle spindle thixotropy. In: Neurosci Lett 1999/264(1-3):109-112.

Wissel J, Kaňovský P, Růžička E, Jech R, Roth J, Brenneis C, Müller J, Schnider P, Auff E, Richardson A, Poewe J. Efficacy and Safety of a Standardized 500 Unit Dose of Dysport in a Heterogenous Cervical Dystonia Population: Results of a Prospective, Multicentre, Randomised, Double-Blind, Placebo-Controled, Parallel-Group Study. In: J Neurol 2001/248(12):1073-1078.

Wissel J, Ward AB, Erztgaard P, Bensmail D, Hecht MJ, Lejeune TM, Schnider P, Altavista MC, Cavazza S, Deltombe T, Duarte E, Geurts AC, Gracies JM, Haboubi NH, Juan FJ, Kasch H, Kätterer C, Kirazli Y, Manganotti P, Parman Y, Paternostro-Sluga T, Petropoulou K, Prempeh R, Rousseaux M, Slawek J, Tieranta N. European consensus table on the use of botulinum toxin type A in adult spasticity. In: J Rehabil Med. 2009/41(1):13-25.

Zborníková P, Králík L, Lelková P, Kalinčík T, Havrdová E, Martásek P. Microsatellite polymorphism in haem oxygenase 1 gene promoter in multiple sclerosis. In: Folia Biol (Praha) 2012/58(2):69-74.

Zemánková M, Jech R. Extrémní hydrocephalus - neurorehabilitační optimismus. In: Rehab Fyzik Lék 2005/2:91-93.

Zemanová (=Hoskovcová), M, Vacek, J. Temporomandibulární dysfunkce, in: Reh. a fyz. lék 2003/3(10):103-108.

Zemanová (=Hoskovcová), M. et al. Neurogenní dysfunkce dolních močových cest, in: Kolektiv autorů (eds.), Neurologie 2005, Triton, Praha 2005.

Zemanová (=Hoskovcová), M., Janda, V. Rehabilitace po obrně lícního nervu, SZÚ 1998.

Zemanová (=Hoskovcová), M., Vacek, J. et al. Whiplash injury, in: Reh. a fyz.lék. 2003/4(10):139-142.

Zemanová (=Hoskovcová), M., Vlková, J. Behaviorální terapie inkontinence moči, in: Lékařské listy 2004/28(53):14-15.

Zikán V, Týblová M, Raška I Jr, Havrdová E, Luchavová M, Michalská D, Kuběna AA. Bone mineral density and body composition in men with multiple sclerosis chronically treated with low-dose glucocorticoids. In: Physiol Res. 2012/6.

Zumrová A, Mušová Z, Havlovicová M, Schwabová J, Jech R, Hlavová E. Syndrom fragilního chromozómu X s tremorem/ataxií (FXTAS): pilotní studie na souboru pacientů nejasné etiologie. In: Čes Slov Neurol N 2007/103(5):558-561.